List of Tables
Table 1. Global Checkpoint Inhibitors for Treating Cancer Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Checkpoint Inhibitors for Treating Cancer Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Checkpoint Inhibitors for Treating Cancer Market Competitive Situation by Manufacturers in 2023
Table 4. Global Checkpoint Inhibitors for Treating Cancer Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Checkpoint Inhibitors for Treating Cancer Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Checkpoint Inhibitors for Treating Cancer Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Checkpoint Inhibitors for Treating Cancer Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Checkpoint Inhibitors for Treating Cancer Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Checkpoint Inhibitors for Treating Cancer, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Checkpoint Inhibitors for Treating Cancer, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Checkpoint Inhibitors for Treating Cancer, Product Type & Application
Table 12. Global Key Manufacturers of Checkpoint Inhibitors for Treating Cancer, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Checkpoint Inhibitors for Treating Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Checkpoint Inhibitors for Treating Cancer as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Checkpoint Inhibitors for Treating Cancer Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Checkpoint Inhibitors for Treating Cancer Sales by Region (2019-2024) & (K Units)
Table 18. Global Checkpoint Inhibitors for Treating Cancer Sales Market Share by Region (2019-2024)
Table 19. Global Checkpoint Inhibitors for Treating Cancer Sales by Region (2025-2030) & (K Units)
Table 20. Global Checkpoint Inhibitors for Treating Cancer Sales Market Share by Region (2025-2030)
Table 21. Global Checkpoint Inhibitors for Treating Cancer Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Region (2019-2024)
Table 23. Global Checkpoint Inhibitors for Treating Cancer Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Region (2025-2030)
Table 25. North America Checkpoint Inhibitors for Treating Cancer Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Checkpoint Inhibitors for Treating Cancer Sales by Country (2019-2024) & (K Units)
Table 27. North America Checkpoint Inhibitors for Treating Cancer Sales by Country (2025-2030) & (K Units)
Table 28. North America Checkpoint Inhibitors for Treating Cancer Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Checkpoint Inhibitors for Treating Cancer Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Checkpoint Inhibitors for Treating Cancer Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Checkpoint Inhibitors for Treating Cancer Sales by Country (2019-2024) & (K Units)
Table 32. Europe Checkpoint Inhibitors for Treating Cancer Sales by Country (2025-2030) & (K Units)
Table 33. Europe Checkpoint Inhibitors for Treating Cancer Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Checkpoint Inhibitors for Treating Cancer Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Checkpoint Inhibitors for Treating Cancer Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Checkpoint Inhibitors for Treating Cancer Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Checkpoint Inhibitors for Treating Cancer Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Checkpoint Inhibitors for Treating Cancer Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Checkpoint Inhibitors for Treating Cancer Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Checkpoint Inhibitors for Treating Cancer Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Checkpoint Inhibitors for Treating Cancer Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Checkpoint Inhibitors for Treating Cancer Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Checkpoint Inhibitors for Treating Cancer Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Checkpoint Inhibitors for Treating Cancer Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Checkpoint Inhibitors for Treating Cancer Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Checkpoint Inhibitors for Treating Cancer Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Checkpoint Inhibitors for Treating Cancer Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Checkpoint Inhibitors for Treating Cancer Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Checkpoint Inhibitors for Treating Cancer Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Checkpoint Inhibitors for Treating Cancer Sales (K Units) by Type (2019-2024)
Table 51. Global Checkpoint Inhibitors for Treating Cancer Sales (K Units) by Type (2025-2030)
Table 52. Global Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type (2019-2024)
Table 53. Global Checkpoint Inhibitors for Treating Cancer Sales Market Share by Type (2025-2030)
Table 54. Global Checkpoint Inhibitors for Treating Cancer Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Checkpoint Inhibitors for Treating Cancer Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Type (2019-2024)
Table 57. Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Type (2025-2030)
Table 58. Global Checkpoint Inhibitors for Treating Cancer Price (USD/Unit) by Type (2019-2024)
Table 59. Global Checkpoint Inhibitors for Treating Cancer Price (USD/Unit) by Type (2025-2030)
Table 60. Global Checkpoint Inhibitors for Treating Cancer Sales (K Units) by Application (2019-2024)
Table 61. Global Checkpoint Inhibitors for Treating Cancer Sales (K Units) by Application (2025-2030)
Table 62. Global Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application (2019-2024)
Table 63. Global Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application (2025-2030)
Table 64. Global Checkpoint Inhibitors for Treating Cancer Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Checkpoint Inhibitors for Treating Cancer Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Application (2019-2024)
Table 67. Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Application (2025-2030)
Table 68. Global Checkpoint Inhibitors for Treating Cancer Price (USD/Unit) by Application (2019-2024)
Table 69. Global Checkpoint Inhibitors for Treating Cancer Price (USD/Unit) by Application (2025-2030)
Table 70. Bristol-Myers Squibb(BMS) Corporation Information
Table 71. Bristol-Myers Squibb(BMS) Description and Business Overview
Table 72. Bristol-Myers Squibb(BMS) Checkpoint Inhibitors for Treating Cancer Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Bristol-Myers Squibb(BMS) Checkpoint Inhibitors for Treating Cancer Product
Table 74. Bristol-Myers Squibb(BMS) Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Checkpoint Inhibitors for Treating Cancer Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Merck Checkpoint Inhibitors for Treating Cancer Product
Table 79. Merck Recent Developments/Updates
Table 80. Roche Corporation Information
Table 81. Roche Description and Business Overview
Table 82. Roche Checkpoint Inhibitors for Treating Cancer Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Roche Checkpoint Inhibitors for Treating Cancer Product
Table 84. Roche Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Checkpoint Inhibitors for Treating Cancer Distributors List
Table 88. Checkpoint Inhibitors for Treating Cancer Customers List
Table 89. Checkpoint Inhibitors for Treating Cancer Market Trends
Table 90. Checkpoint Inhibitors for Treating Cancer Market Drivers
Table 91. Checkpoint Inhibitors for Treating Cancer Market Challenges
Table 92. Checkpoint Inhibitors for Treating Cancer Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Checkpoint Inhibitors for Treating Cancer
Figure 2. Global Checkpoint Inhibitors for Treating Cancer Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Checkpoint Inhibitors for Treating Cancer Market Share by Type in 2023 & 2030
Figure 4. PD-1 Inhibitors Product Picture
Figure 5. PD-L1 Inhibitors Product Picture
Figure 6. CTLA-4 Inhibitors Product Picture
Figure 7. Global Checkpoint Inhibitors for Treating Cancer Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Checkpoint Inhibitors for Treating Cancer Market Share by Application in 2023 & 2030
Figure 9. Melanoma Treatment
Figure 10. Bladder Cancer Treatment
Figure 11. Other
Figure 12. Global Checkpoint Inhibitors for Treating Cancer Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Checkpoint Inhibitors for Treating Cancer Market Size (2019-2030) & (US$ Million)
Figure 14. Global Checkpoint Inhibitors for Treating Cancer Sales (2019-2030) & (K Units)
Figure 15. Global Checkpoint Inhibitors for Treating Cancer Average Price (USD/Unit) & (2019-2030)
Figure 16. Checkpoint Inhibitors for Treating Cancer Report Years Considered
Figure 17. Checkpoint Inhibitors for Treating Cancer Sales Share by Manufacturers in 2023
Figure 18. Global Checkpoint Inhibitors for Treating Cancer Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Checkpoint Inhibitors for Treating Cancer Players: Market Share by Revenue in 2023
Figure 20. Checkpoint Inhibitors for Treating Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Checkpoint Inhibitors for Treating Cancer Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Country (2019-2030)
Figure 23. North America Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Checkpoint Inhibitors for Treating Cancer Sales Market Share by Country (2019-2030)
Figure 27. Europe Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Country (2019-2030)
Figure 28. Germany Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Checkpoint Inhibitors for Treating Cancer Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Region (2019-2030)
Figure 35. China Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Checkpoint Inhibitors for Treating Cancer Sales Market Share by Country (2019-2030)
Figure 45. Latin America Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Checkpoint Inhibitors for Treating Cancer Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Checkpoint Inhibitors for Treating Cancer by Type (2019-2030)
Figure 55. Global Revenue Market Share of Checkpoint Inhibitors for Treating Cancer by Type (2019-2030)
Figure 56. Global Checkpoint Inhibitors for Treating Cancer Price (USD/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Checkpoint Inhibitors for Treating Cancer by Application (2019-2030)
Figure 58. Global Revenue Market Share of Checkpoint Inhibitors for Treating Cancer by Application (2019-2030)
Figure 59. Global Checkpoint Inhibitors for Treating Cancer Price (USD/Unit) by Application (2019-2030)
Figure 60. Checkpoint Inhibitors for Treating Cancer Value Chain
Figure 61. Checkpoint Inhibitors for Treating Cancer Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
